Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:1183-1190
Published online before print August 16, 2004, doi: 10.1161/01.CIR.0000140765.71014.1C
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/10/1183    most recent
01.CIR.0000140765.71014.1Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wichterle, D.
Right arrow Articles by Malik, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wichterle, D.
Right arrow Articles by Malik, M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Electrocardiology
Right arrowRelated Article

(Circulation. 2004;110:1183-1190.)
© 2004 American Heart Association, Inc.


Original Articles

Prevalent Low-Frequency Oscillation of Heart Rate

Novel Predictor of Mortality After Myocardial Infarction

Dan Wichterle, MD; Jan Simek, MD; Maria Teresa La Rovere, MD; Peter J. Schwartz, MD; A. John Camm, MD; Marek Malik, MD, PhD

From the Department of Cardiological Sciences, St George’s Hospital Medical School, London, UK (D.W., A.J.C., M.M.); Department of Internal Medicine, General University Hospital, Prague, Czech Republic (D.W., J.S.); Division of Cardiology, Fondazione "S. Maugeri" IRCCS, Montescano, Italy (M.T.L.R.); and Department of Cardiology, Policlinico S. Matteo IRCCS and University of Pavia, Pavia, Italy (P.J.S.).

Correspondence to Dr Marek Malik, Cardiological Sciences, St. George’s Hospital Medical School, London SW17 0RE UK. E-mail m.malik{at}sghms.ac.uk

Received January 16, 2004; de novo received April 1, 2004; revision received May 12, 2004; accepted May 18, 2004.

Background— This study evaluates a novel method for postinfarction risk stratification based on frequency-domain characteristics of heart rate variability (HRV) in 24-hour Holter recordings.

Methods and Results— A new risk predictor, prevalent low-frequency oscillation (PLF), was determined in the placebo population of the European Myocardial Infarction Amiodarone Trial (EMIAT). Frequencies of peaks detected in 5-minute low-frequency HRV spectra were averaged to obtain the PLF index. PLF ≥0.1 Hz was the strongest univariate predictor of all-cause mortality associated with relative risk of 6.4 (95% CI, 3.9 to 10.6; P<10–12). In a multivariate Cox’s regression model including clinical risk factors, mean RR interval, HRV index, low- and high-frequency HRV spectral power, and heart rate turbulence, PLF was the most powerful mortality predictor, with a relative risk of 4.6 (95% CI, 2.2 to 9.3; P=0.00003). Predictive power of PLF was blindly validated in the population of the Autonomic Tone and Reflexes After Myocardial Infarction (ATRAMI) trial. PLF ≥0.1 Hz was associated with univariate relative risk of 6.1 (95% CI, 2.9 to 12.9; P<10–5) for cardiac mortality or resuscitated cardiac arrest. In multivariate Cox’s regression model including age, left ventricular ejection fraction, baroreflex sensitivity, mean RR interval, standard deviation of normal RR intervals, low- and high-frequency HRV spectral power, and heart rate turbulence, only left ventricular ejection fraction and PLF were significant predictors, with relative risks of 4.2 (95% CI, 1.5 to 11.7; P=0.007) and 3.6 (95% CI, 1.3 to 10.5; P=0.02), respectively.

Conclusions— An innovative analysis of frequency-domain HRV, which characterizes the distribution of spectral power within the low-frequency band, is a potent and independent risk stratifier in postinfarction patients.


Key Words: electrocardiography • heart rate • mortality • myocardial infarction • risk factors


Related Article:


Circulation 2004 110: 1177. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Diabetes CareHome page
H. J.B.H. Beijers, I. Ferreira, B. Bravenboer, J. M. Dekker, G. Nijpels, R. J. Heine, and C. D.A. Stehouwer
Microalbuminuria and Cardiovascular Autonomic Dysfunction Are Independently Associated With Cardiovascular Mortality: Evidence for Distinct Pathways: The Hoorn Study
Diabetes Care, September 1, 2009; 32(9): 1698 - 1703.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
J.-H. Baumert, M. Hein, K. E. Hecker, S. Satlow, J. Schnoor, and R. Rossaint
Autonomic cardiac control with xenon anaesthesia in patients at cardiovascular risk
Br. J. Anaesth., June 1, 2007; 98(6): 722 - 727.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Watanabe, P. Guzik, M. Malik, D. Wichterle, A. J. Camm, J. Simek, M. T. La Rovere, and P. J. Schwartz
Letter Regarding Article by Wichterle et al, "Prevalent Low-Frequency Oscillation of Heart Rate: Novel Predictor of Mortality After Myocardial Infarction" * Response
Circulation, April 12, 2005; 111(14): e180 - e181.
[Full Text] [PDF]